Submitted by Anonymous (not verified) on 26 September 2025 - 15:46
Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 10/06/2022, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 10/06/2022, Revision: 17, Status: Authorised